We formulated the vaccine by incorporating the characterized antigenic peptides to pre-formed CaPNPs through physical adsorption
We formulated the vaccine by incorporating the characterized antigenic peptides to pre-formed CaPNPs through physical adsorption. and -A24 binding DV serotypes conserved epitopes, and the feasibility of an epitope based…